Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.

Source:http://linkedlifedata.com/resource/pubmed/id/10971644

Download in:

View as

General Info

PMID
10971644